| Literature DB >> 29247115 |
Jack Charles Collins1, Carl Richard Schneider1, Clare Louise Naughtin1, Frances Wilson1, Abilio Cesar de Almeida Neto1, Rebekah Jane Moles1.
Abstract
OBJECTIVES: To determine whether repeated mystery shopping visits with feedback improve pharmacy performance over nine visits and to determine what factors predict an appropriate outcome.Entities:
Keywords: community pharmacy; minor ailment; nonprescription medicine; pharmacy; simulated patient
Mesh:
Substances:
Year: 2017 PMID: 29247115 PMCID: PMC5735410 DOI: 10.1136/bmjopen-2017-019462
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Example of appropriate outcome for each scenario
| Scenario | Appropriate outcome |
| Adult cough/cold | Identification of dextromethorphan–SSRI interaction and alternative product recommendation |
| Adult pain | Identification of duplication of therapy (ibuprofen and celecoxib) |
| Allergic rhinitis | Identification of trigger factors and appropriate treatment with an intranasal corticosteroid |
| Asthma | Identification of frequent salbutamol use and poorly controlled asthma, referral to a medical practitioner |
| Diarrhoea | Identification of ‘red flag’ symptoms such as recent overseas travel, referral to a medical practitioner |
| Dyspepsia | Identification of ‘red flag’ symptoms such as frequent symptoms, referral to a medical practitioner |
| Insomnia | Counselling on sleep hygiene |
| Paediatric cough/cold | Refusal of supply of product for a child aged <6 years |
| Paediatric fever | Appropriate weight-based dosing |
| Smoking cessation | Identification of caffeine–cigarette smoke interaction |
SSRI, selective serotonin reuptake inhibitor.
Results of overall appropriate outcome over time by scenario
| Scenario | Visits 1–3 (%) | Visits 4–6 (%) | Visits 7–9 (%) | Overall (%) | Improvement over time* |
| Adult cough/cold (n=52) | 17 | 41 | 53 | 37 | Yes (P=0.044) |
| Adult pain (n=52) | 67 | 53 | 71 | 64 | No (P=0.725) |
| Allergic rhinitis (n=50) | 6 | 18 | 27 | 16 | Yes (P=0.018) |
| Asthma (n=54) | 50 | 83 | 78 | 70 | No (P=0.067) |
| Diarrhoea (n=51) | 50 | 65 | 56 | 57 | No (P=0.427) |
| Dyspepsia (n=53) | 78 | 65 | 67 | 70 | No (P=0.823) |
| Insomnia (n=53) | 33 | 77 | 61 | 57 | No (P=0.073) |
| Paediatric cough/cold (n=54) | 72 | 83 | 78 | 78 | No (P=0.901) |
| Paediatric fever (n=51) | 47 | 53 | 94 | 65 | Yes (P=0.010) |
| Smoking cessation (n=51) | 12 | 19 | 50 | 28 | Yes (P=0.005) |
| All (n=521) | 43 | 56 | 64 | 54 | Yes (P<0.001) |
*Significance determined by point–biserial analyses, P<0.05.
Median questioning scores and IQR over time by scenario
| Scenario | Visits 1–3 (%) | Visits 4–6 (%) | Visits 7–9 (%) | Overall (%) | Improvement over time* |
| Adult cough/cold (n=52) | 37 (IQR=25–67) | 58 (IQR=40–83) | 64 (IQR=50–83) | 58 (IQR=33–83) | Yes (P=0.003) |
| Adult pain (n=52) | 46 (IQR=21–86) | 57 (IQR=43–79) | 64 (IQR=50–100) | 57 (IQR=39–86) | Yes (P=0.008) |
| Allergic rhinitis (n=50) | 25 (IQR=0–72) | 31 (IQR=0–50) | 33 (IQR=0–50) | 28 (IQR=0–50) | No (P=0.929) |
| Asthma (n=54) | 30 (IQR=14–64) | 42 (IQR=31–72) | 62 (IQR=36–86) | 44 (IQR=25–72) | Yes (P=0.004) |
| Diarrhoea (n=51) | 44 (IQR=19–81) | 44 (IQR=28–73) | 44 (IQR=25–66) | 44 (IQR=25–70) | No (P=0.707) |
| Dyspepsia (n=53) | 50 (IQR=25–81) | 75 (IQR=21–81) | 75 (IQR=13–89) | 63 (IQR=22–81) | No (P=0.198) |
| Insomnia (n=53) | 44 (IQR=25–63) | 69 (IQR=50–81) | 56 (IQR=25–78) | 56 (IQR=33–78) | No (P=0.274) |
| Paediatric cough/cold (n=54) | 22 (IQR=14–50) | 28 (IQR=25–50) | 38 (IQR=25–50) | 30 (IQR=19–50) | No (P=0.227) |
| Paediatric fever (n=51) | 11 (IQR=11–22) | 39 (IQR=17–56) | 44 (IQR=25–72) | 22 (IQR=11–56) | Yes (P=0.002) |
| Smoking cessation (n=51) | 44 (IQR=22–83) | 53 (IQR=25–69) | 58 (IQR=28–94) | 56 (IQR=22–78) | No (P=0.290) |
| All (n=521) | 38 (IQR=14–64) | 50 (IQR=25–72) | 50 (IQR=26–76) | 44 (IQR=22–75) | Yes (P<0.001) |
*Significance determined by Spearman’s rank order correlations, P<0.05.
Factors predicting appropriate outcome of mystery shopping scenarios—binary logistic regression model output (Nagelkerke R2=0.60)
| Variable | β coefficient | OR | 95 | P value | |
| Lower bound | Upper bound | ||||
| Pharmacist involvement in interaction | 0.398 | 1.489 | 1.111 | 1.996 | 0.008** |
| Mystery shopping visit number (1–9) | 0.110 | 1.113 | 1.016 | 1.226 | 0.022* |
| Questioning score | 0.062 | 1.063 | 1.050 | 1.077 | <0.001*** |
| Legislative status of product requested | 0.186 | 1.204 | 0.483 | 3.000 | 0.691 |
| Mystery shopper identified by pharmacy staff | 0.405 | 1.500 | 0.875 | 2.572 | 0.140 |
| Individual pharmacy† | −0.010 | 0.990 | 0.968 | 1.014 | 0.418 |
| Allergic rhinitis scenario (reference scenario) | <0.001*** | ||||
| Adult cough/cold scenario | 0.211 | 1.235 | 0.381 | 4.005 | 0.752 |
| Adult pain scenario | 1.754 | 5.779 | 1.307 | 25.555 | 0.021* |
| Asthma scenario | 2.868 | 17.596 | 3.762 | 82.301 | <0.001*** |
| Diarrhoea scenario | 2.072 | 7.943 | 2.071 | 30.459 | 0.003** |
| Dyspepsia scenario | 2.900 | 18.182 | 4.462 | 74.093 | <0.001*** |
| Insomnia scenario | 1.274 | 3.576 | 0.813 | 15.740 | 0.092 |
| Paediatric cough/cold scenario | 4.463 | 86.770 | 24.328 | 309.478 | <0.001*** |
| Paediatric fever scenario | 3.623 | 37.437 | 10.723 | 130.699 | <0.001*** |
| Smoking cessation scenario | 0.024 | 1.024 | 0.113 | 9.251 | 0.983 |
*Significant at 0.05 level.
**Significant at 0.01 level.
***Significant at 0.001 level.
†Pharmacy was not broken down further due to not returning a significant value.